Flex-able
Flex-able, licence 80056058: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Hummingbird Natural Pharmaceutical Inc.
- NPN or DIN-HM
- 80056058
- Status
- Active licence
- Licence date
- 28 November 2014
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Harpagophytum procumbens Source : Harpagophytum procumbens, racine | 50.0 mg | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione | 76.0 mg | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : exosquelettes de homards | 500.0 mg | Not calculated |
| Boswellia sacra Source : Boswellia sacra - résine (écorce de tige) | 50.0 mg | Not calculated |
| Méthylsulfonylméthane | 300.0 mg | Not calculated |
| Acide L-ascorbique Source : Abelmoschus esculentus- plante entière | 20.0 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Helps to protect against the deterioration of cartilage. A factor in maintaining healthy cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding.
- Précautions et mises en garde
If symptoms worsen, consult a health care practitioner. Consult a health care practitioner prior to use if you are taking antiplatelet medication or blood thinners. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid.
- Effets indésirables connus
Some people may experience mild gastrointestinal bloating, constipation or indigestion.
Source
Official Health Canada record, licence 80056058
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.